Company Overview of N8 Medical, LLC
N8 Medical, LLC, a biomedical technology company, develops a class of commercial compounds for medical device and pharmaceutical applications. The company focuses on creating medical devices and pharmaceuticals to combat a spectrum of infectious diseases and microbes. It develops ceragenin technology that comprise the formulations of ceragenins and cationic selective antimicrobials (CSA), which show bactericidal, fungicidal, and virucidal results against a variety of pathogens, including gram-positive and gram-negative bacteria, as well as multi-drug resistant strains of bacteria, such as Methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa. The company also provides LifeGu...
Key Executives for N8 Medical, LLC
Vice President of Development and General Counsel
Vice President of Licensing and Device Development
Compensation as of Fiscal Year 2017.
N8 Medical, LLC Key Developments
FDA Grants N8 Medical's Request for Breakthrough Device Designation for its CeraShield(TM) Endotracheal Tube
May 4 17
N8 Medical, LLC announced that the United States Food and Drug Administration (FDA) has approved the company's request to designate its CeraShield(TM) endotracheal tube as a "breakthrough device" pursuant to the recently-enacted 21st Century Cures Act. A "breakthrough device" is a device that may prevent or treat a life-threatening or irreversibly debilitating disease or condition. The N8 Medical CeraShield(TM) Endotracheal Tube is a specially-modified endotracheal tube that has been coated with a proprietary ceragenin compound formulation designed to prevent bacterial and fungal growth on the tube's surfaces. Patients who require mechanical ventilation in the ICU are intubated with endotracheal tubes to provide oxygen to the patient's lungs to assist with breathing. Within hours of intubation, bacteria and fungi may start to grow on the tube and form microbial aggregations known as biofilms. The CeraShield(TM) medical device coating technology is applicable to a broad range of medical devices commonly colonized with pathogenic bacteria and fungi, including devices for urology, vascular access, cardiology, orthopedics, and ear nose and throat (ENT), as well as other respiratory devices such as tracheostomy tubes. N8 Medical is working to pursue broad application of its CeraShield(TM) coating technology to create best-in-class antimicrobial medical devices designed to reduce the morbidity and, mortality and high costs and use of resources associated with hospital-acquired infections worldwide-both through independent commercialization efforts and through collaboration and partnering opportunities.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries